Cibus Global LLC (CBUS) - Total Liabilities

Latest as of March 2026: $288.72 Million USD

Based on the latest financial reports, Cibus Global LLC (CBUS) has total liabilities worth $288.72 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Cibus Global LLC growing its equity to track the company's year-over-year net asset growth rate.

Cibus Global LLC - Total Liabilities Trend (2015–2025)

This chart illustrates how Cibus Global LLC's total liabilities have evolved over time, based on quarterly financial data.

Cibus Global LLC Competitors by Total Liabilities

The table below lists competitors of Cibus Global LLC ranked by their total liabilities.

Company Country Total Liabilities
Daechang Forgi
KO:015230
Korea ₩81.19 Billion
OptiNose
NASDAQ:OPTN
USA $176.22 Million
RiTdisplay Corp
TW:8104
Taiwan NT$5.23 Billion
Global Lights Acquisition Corp Ordinary Shares
NASDAQ:GLACF
USA $2.99 Million
Flexopack Société Anonyme Commercial and Industrial Plastics Company
AT:FLEXO
Greece €86.08 Million
Centro de Imagem Diagnósticos S.A
SA:AALR3
Brazil R$1.93 Billion
Global Lights Acquisition Corp Ordinary Shares
NASDAQ:GLAC
USA $2.99 Million
Edimax Technology Co Ltd
TW:3047
Taiwan NT$3.13 Billion

Liability Composition Analysis (2015–2025)

This chart breaks down Cibus Global LLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Cibus Global LLC stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.37 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 8.14 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.89 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cibus Global LLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cibus Global LLC (2015–2025)

The table below shows the annual total liabilities of Cibus Global LLC from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 $283.22 Million +12.28%
2024-12-31 $252.24 Million +22.38%
2023-12-31 $206.12 Million +1257.10%
2022-12-31 $15.19 Million -34.14%
2021-12-31 $23.06 Million -12.82%
2020-12-31 $26.45 Million +3.37%
2019-12-31 $25.59 Million +0.77%
2018-12-31 $25.39 Million +72.85%
2017-12-31 $14.69 Million +319.26%
2016-12-31 $3.50 Million +101.61%
2015-12-31 $1.74 Million --

About Cibus Global LLC

NASDAQ:CBUS USA Biotechnology
Market Cap
$147.32 Million
Market Cap Rank
#19219 Global
#4371 in USA
Share Price
$1.93
Change (1 day)
+0.00%
52-Week Range
$1.16 - $4.05
All Time High
$1574.00
About

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-th… Read more